Studies of cell fate focus on specification, but little is known about maintenance of the 12 differentiated state. We find that TGFβ signaling plays an essential role in maintenance of the 13 tendon cell fate. To examine the role TGFβ signaling in tenocytes TGF type II receptor was 14 targeted in the Scleraxis cell lineage. Tendon development was not disrupted in mutant 15 embryos, but shortly after birth tenocytes lost differentiation markers and reverted to a more 16 stem/progenitor state. Targeting of Tgfbr2 using other Cre drivers did not cause tenocyte 17 dedifferentiation suggesting a critical significance for the spatio-temporal activity of ScxCre. 18 Viral reintroduction of Tgfbr2 to mutants was sufficient to prevent and even rescue mutant 19 tenocytes suggesting a continuous and cell-autonomous role for TGFβ signaling in cell fate 20 maintenance. These results uncover the critical importance of molecular pathways that 21 maintain the differentiated cell fate and a key role for TGFβ signaling in these processes. 22 23 24 25 26 27 28 29
Introduction 30 Studies of cell fate determination are in most cases focused on the signaling pathways and 31 transcription factors that direct naïve cells to assume a specific cell fate (Li et al., 2012; James, 32 2013; Huang et al., 2015) . It is commonly accepted that once fully differentiated the cells enter 33 a stable cellular phenotype, but relatively little is known about the molecular mechanisms that 34 reinforce and maintain this differentiated state. Maintenance of the differentiated state is 35 however essential for tissue function and identifying the molecular pathways involved in these 36 processes may be of great importance for understanding tissue homeostasis and pathology. 37 Tendons are connective tissues that transmit forces from muscle to bone to generate 38 movement (Kannus, 2000) . Despite their importance to overall musculoskeletal function and 39 their slow and limited healing capabilities, relatively little is known about tendon development, 40 the tendon cell fate, maturation and pathology. Elucidating the key molecular regulators of 41 these processes is thus essential for improvements in the management of tendon healing, the 42 treatment of tendinopathy and for bioengineering efforts for this tissue. 43 A limited number of transcription factors were so far identified as key regulators of the 44 tendon cell fate including most notably, Scleraxis (Scx), a bHLH transcription factor expressed in 45 tendon cells from progenitor stages and through development (Schweitzer et al., 2001) and 46 Mohawk (Mkx), an atypical homeobox protein with essential roles in the development of the 47 collagen matrix in tendons (Ito et al., 2010) . Prototypic markers for the tendon cell fate also 48 include the transmembrane protein tenomodulin (Tnmd) and collagen type I (Kannus, 2000 ; 49 Huang et al., 2015), the major building blocks of the tendon fibrillar extracellular matrix that 50 mediates the transmission of force by tendons. 51 Previous studies have also established a central role for the transforming growth factor-β , 1997) . The goal of this study was 61 therefore to ask if TGFβ signaling plays essential roles at later stages of tendon development. 62 The TGFβ superfamily comprises secreted polypeptides that regulate diverse developmental 63 processes ranging from cellular growth, differentiation and migration to tissue patterning and 64 morphogenesis (Santibanez et al., 2011; Sakaki-Yumoto et al., 2013). These ligands act by 65 binding to transmembrane type II receptors, which in turn recruit and activate a type I receptor. 66 The activated receptor complex subsequently phosphorylates and activates receptor-regulated 67 transcription factors called Smads (Smad2/3 for TGFβ signaling) that subsequently complex 68 with the common-mediator Smad4 and translocate into the nucleus where they promote or 69 repress responsive target genes (Vander Ark et al., 2018) . The TGFβ proper ligands (TGFβ1-3) all 70 bind to a single type II receptor. Consequently, disrupting this one receptor is sufficient to 71 abrogate all TGFβ signaling. To test for additional roles of TGFβ signaling in tendon 72 development and biology we wanted to bypass the early essential function in tendon formation, 73 and decided to target TGF type II receptor (Tgfbr2) explicitly in tendon cells. We therefore 74 targeted the receptor using ScxCre (Blitz et al., 2013) , a tendon specific Cre driver, so that TGFβ 75 signaling will be disrupted specifically in tendon cells and only after the initial events of tendon 76 formation. 77 We find that tendon differentiation function and growth during embryonic development 78 was not disrupted following targeted deletion of TGFβ signaling in tenocytes, but shortly after 79 birth the cells lost tendon cell differentiation markers and reverted to a more progenitor-like 80 state. Moreover, viral reintroduction of Tgfbr2 to mutant cells was sufficient to prevent 81 dedifferentiation and even to rescue the tendon cell fate in a cell-autonomous manner, 82 highlighting a continuous and essential role of TGFβ signaling in maintenance of the tendon cell 83 fate. 84 
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Results
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Targeting TGF type II receptor in Scx-expressing cells resulted in tendon disruption and limb 87 abduction 88 Our previous studies showed that disruption of TGF signaling in limb mesenchyme resulted in 89 the complete failure of tendon formation (Pryce et al., 2009). To examine later roles of TGFβ 90 signaling in tendon development we targeted Tgfbr2 with ScxCre thereby bypassing the early 91 role of TGFβ signaling for tendon development. Tgfbr2;ScxCre mutant embryos indeed 92 developed a complete network of tendons by E14.5, indicating they have bypassed the early 93 requirement for TGF signaling in tendon development ( Fig. 1A) . 94 Mutant tendon development was not perturbed through embryogenesis and mutant pups 95 appeared normal at birth (Fig. 1C ). However, by day 3 after birth (P3), mutant pups showed 96 physical abnormalities that manifested in abducted paws, splayed limbs ( as well as ligaments and annulus fibrosus of the intervertebral disc ( Fig. 1D ,E). Movement 105 limitations were exacerbated as mutant pups became older and all mutants died at or before 106 P14. This phenotypic progression was observed in most mutant pups but intriguingly, in rare 107 cases (~2%) the mutant pups showed physical abnormalities and severe tendon phenotypes 108 already at birth. 109 A closer examination of the mutant embryos identified the first indication of a tendon 110 phenotype already at E16.5. The flexor carpi radialis tendons of mutant embryos were 111 consistently torn by E16.5 (Fig. S2 ). Interestingly, this phenotype was highly reproducible while 112 the patterning and development of other tendons in mutant embryos was not perturbed 113 through embryogenesis. Moreover, expression of the prototypic tenocyte markers Scx, Tnmd 114 and collagen I ( Fig. 2A -D) and the development of the collagen matrix were not disrupted in any 115 tendon of mutant embryos ( Fig. 2E,F) , including the flexor carpi radialis tendon before it 116 snapped. A direct cause for the specific tear of the flexor carpi radialis tendon in mutant 117 embryos was not identified to date. 118 Tendons are rich in collagen fibers that provide structural integrity to the tendons and 119 transmit the forces generated by muscle contraction (Kannus, 2000) . Since young mutant pups 120 exhibited movement difficulties we first examined possible structural effects in the collagen 121 matrix. The ultrastructure of mutant tendons that remained intact was therefore analyzed by 122 transmission electron microscopy (TEM) . Surprisingly, despite the functional defects starting 123 around P3, collagen fibers in mutant tendons appeared organized and indistinguishable from 124 those of wild-type (WT) littermates at this stage ( Fig. 3 ). Apparent collagen degradation was 125 observed only in older mutant pups (≥ P7) ( Fig. 3 ), suggesting the disruption to the matrix of 126 these tendons may be a secondary consequence of the cellular changes in these mutants 127 and/or of their movement difficulties. Furthermore, epitenon, a monolayer of cells that engulf 128 and define the boundary of the tendon (Kannus, 2000) ( Fig. 3 , black arrowhead), was gradually 129 disrupted and in some cases was almost undetectable in older mutant pups ( Fig. 3 , white 130 arrowhead), suggesting that loss of the tendon boundary is an additional feature of the 131 phenotype in these mutants.
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Loss of the tendon cell fate in mutant tenocytes 134 As mentioned earlier, the ScxGFP signal in mutant tendons appeared patchy contrary to the 135 smooth appearance of WT tendons ( Fig. 1B ), suggesting a disruption at the cellular level. To 136 examine this phenotype at the cellular level we analyzed cross sections through the extensor 137 communis tendons of P7 WT and mutant pups. In P7 WT pups, all tendon cells were positive for 138 ScxGFP, Tnmd and Col1a1 (Fig. 4A,C) . Conversely, most cells in mutant tendons lost the ScxGFP 139 signal and tendon marker gene expression ( Fig. 4B , white arrowhead and 4C). Interestingly, 140 some cells in mutant tendons retained ScxGFP signal and appeared rounded and enlarged from 141 P3 onwards ( Fig. 4B , yellow arrowhead). Further investigation suggests that these cells are 142 6 newly recruited tendon cells. Analysis of this aspect of the mutant phenotype will be published 143 in a separate manuscript (Tan et al., manuscript in preparation). 144 The fact that most cells in the mutant tendons do not express tendon markers is surprising, 145 since the cells in these tendons were functional tenocytes at embryonic stages as evidenced by 146 tendon marker gene expression and by the development of a functional collagen matrix (Fig. 2) . 147 We next sought to determine if the ScxGFP-negative cells were indeed tendon cells that lost 148 tendon gene expression or if the mutant tendons were simply repopulated by non-tenogenic 149 cells. Using TUNEL assay we did not detect cell death in mutant tendons and the rate of 150 tenocyte proliferation as examined by EdU assay was also not altered in these tendons (Fig. 151 S3A,B), suggesting the cell population of mutant tendons was not altered. To directly determine 152 if the cells in mutant tendons were tenocytes whose cell fate was altered, we took advantage of As aforementioned, we found no apparent cell death in mutant tendons ( Fig. S3A ). Using 176 histological staining for the prototypic markers of osteocytes, adipocytes and chondrocytes we 177 found that loss of tendon gene expression in the cells of mutant tendons was also not due to 178 transdifferentiation ( Fig. S3C ), suggesting that the changes in mutant tendons may reflect a 179 process of cellular dedifferentiation. 180 One hallmark of cellular dedifferentiation is the loss of differentiation markers, which is 181 what we observed in mutant tendon cells. When cells dedifferentiate they also assume 182 stemness features e.g. colony forming potential, and in most cases these cells also acquire increase (p<0.01) in the frequency of colony forming cells in mutant tendons ( Fig. 5A ). 199 We next screened the mutant tendons for expression of stem/progenitor cell markers. We 200 found that while Tgfbr2;ScxCre mutant tendon cells exhibited weak or negative expression of 201 some progenitor markers e.g. CD90.2, Oct-3/4, Sox2, nucleostemin, alpha-SMA, nestin and Sox9 202 (data not shown), the mutant tendon cells gradually acquired expression of stem cell antigen-1 203 (Sca-1) and CD44 in postnatal stages ( Fig. 5B) . Notably, expression of Sca-1 was undetectable 204 and CD44 was detected only in very few WT tendon cells, but surprisingly robust expression of 205 these markers was detected in the epitenon ( similarity of marker expression between the mutant tenocytes and epitenon cells therefore 208 reinforces the notion that the mutant tenocytes acquired progenitor features. 209 Dedifferentiation is frequently associated with reversion to an earlier progenitor cell fate 210 (Cai et al., 2007) . We therefore next examined the expression of these markers during Molecular profile of the dedifferentiated mutant tenocytes 229 We next performed single cell RNA sequencing analysis (scRNASeq) to establish a 230 comprehensive profile of the cellular state and molecular changes in mutant tenocytes. A 231 targeted retention of 2300-2600 cells from P7 WT-and mutant tendon was obtained, and the 232 transcriptomes were analyzed using the 10X Genomics platform. Using unsupervised 233 hierarchical clustering analysis, we identified two major clusters corresponding to WT tenocytes 234 and mutant (dedifferentiated) cells in the respective samples. Expression of close to 1000 genes 235 (mean UMI count  0.5, adjusted p-value  0.05) was identified in each of these clusters. 236 Pairwise comparison of the gene set between the P7 WT tenocyte and mutant cell clusters 237 was next performed to determine changes in gene expression associated with tenocyte 238 dedifferentiation. In total, expression of 186 genes was significantly different between the two 239 cell populations ( 2-fold change and adjusted p-value  0.05), in which expression of 89 genes 240 was upregulated and 97 genes was downregulated in the mutant tendon cells (Table S2 ). (Table 1) , further confirming the loss-of-245 cell fate phenotype in these cells. On the other hand, expression of the Ly6a gene (encoding 246 Sca-1) was greatly enriched in P7 mutant cells, corroborating the IHC findings presented above 247 (Table 2 and Fig. 5B ). Moreover, we also found a significant increase in the expression of the 248 CD34 gene, another common marker for diverse progenitor cells. This observation was further 249 confirmed at protein level, where positive immunostaining for CD34 was detected in mutant 250 cells but not in normal tendon cells ( Fig. 6A) . Interestingly, the genes upregulated in the mutant 251 cells included several genes (Dpt, Anxa1, CD34, CD44, Mgp and Mfap5) whose expression was 252 previously reported to be enriched during embryonic tendon development (Havis et al., 2014) . 253 These findings thus do not only lend support to our notion that the mutant cells lost their 
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To gain insights into biological functions activated in the P7 mutant cells, differentially 258 expressed genes (DEGs) in these cells (Table S2) were further analyzed via GO enrichment tools 259 clusterProfiler (Yu et al., 2012) and PANTHER Classification System (http://pantherdb.org/). 260 Intriguingly, GO enrichment analysis revealed that one of the prominent biological changes 261 observed in P7 mutant cells was upregulation of gene sets associated with wound healing (Fig. 262 6B and Table S3 ). These genes include protease inhibitors (Serpine2, Serping1), inflammatory Table S3 ). Since tendon biology is not annotated in most databases, 268 changes in the collagen matrix, the most prominent structural component in tendons is the 269 best indicator for the disruption of the tendon cell fate. Disruption of the collagen matrix in 270 tendons was also detected in older mutant pups by ultrastructural analysis using TEM ( Fig. 3) . 271 Using PANTHER, we also investigated which protein classes were significantly altered in P7 272 mutant cells relative to WT tenocytes. Genes found to be most downregulated in mutant cells 273 encode for receptors, signaling molecules, membrane traffic proteins and ECM (Table 3A) . On 274 the other hand, the upregulated genes in the mutant cells encode most prominently for 275 proteins involved in nucleic acid binding, enzyme modulators, cytoskeletal protein, signaling 276 molecules and transcription factors (Table 3B) . Notably, expression of the activating protein 1 277 (AP-1) transcriptional complex, associated with numerous cellular processes including cell fate 278 regulation (Hess et al., 2004) , was significantly induced in mutant cells. Expression of both AP-1 279 components, i.e. the Fos and Junb genes was induced more than two fold, and the Jun gene was 280 induced only slightly less than 2 fold. Moreover, the Id3 gene encoding for a general bHLH 281 transcription factor inhibitor was also induced. Due to its broad selection of targets, Id3 was 282 also implicated in numerous cellular processes including the regulation of cellular 283 differentiation (Norton, 2000) . A possible role for these transcriptional activities in tenocyte 284 dedifferentiation will be addressed in future studies. 285 We next conducted PANTHER Pathway Analysis using different values of the filter 286 parameter (mean UMI count and fold change) for enriching DEGs in P7 mutant cells. In general, 287 we found that pathways that stood out as relevant for this study included integrin signaling, 288 insulin/IGF, Wnt and inflammation mediated by chemokine and cytokine signaling pathways 289 (Table 4) Tgfbr2-V5 in individual mutant tendon cell at both developmental stages was able to prevent 313 the loss of tendon markers as observed in postnatal pups ( Fig. 7B-D ), suggesting a cell 314 autonomous role for TGFβ signaling in maintenance of the tendon cell fate. 315 Recognizing that cell autonomous activity of Tgfbr2-V5 was sufficient to prevent 316 dedifferentiation of mutant tenocytes, we next wanted to test if reactivation of TGFβ signaling 317 in a dedifferentiating tenocyte could also reverse the process and rescue a tenocyte from 318 dedifferentiation. Activity of ScxCre may be lost in the dedifferentiating tenocytes due to the 319 loss of Scx expression and therefore of Scx enhancer driven expression of Cre in ScxCre mice. 320 We therefore used in this case a virus encoding constitutive expression of Tgfbr2 in which the 321 virus was tagged with a FLAG Tag (AAV1-Tgfbr2-FLAG). The virus was injected locally into P1 322 mutant limbs and the limbs were harvested at P7. We found that all infected mutant tendon 323 cells expressed the tendon markers ScxGFP and tenomodulin ( Fig. 7D and Fig. S5A ), suggesting 324 that reactivation of TGFβ signaling was indeed sufficient to rescue the dedifferentiated 325 tenocytes. Taken together, these findings demonstrate that TGFβ signaling is sufficient to 326 prevent and to rescue the loss-of-tendon cell fate in a cell-autonomous manner. 327 The constitutive expression of Tgfbr2-FLAG driven by the AAV1-Tgfbr2-FLAG virus ensured this study therefore suggest that a similar process may be activated in tenocytes as part of the 400 regenerative process in response to pathology. Taken together, this growing body of evidence 401 suggests that dedifferentiation may be a generalized cellular response to tissue damage that 402 warrants further investigation. Moreover, these observations may also suggest that induction 403 of Sca-1 may serve as a marker for a pathology-related dedifferentiation process. Intriguingly, 404 Sca-1 positive cells were also found in the wound window in rat patellar tendon incisional injury The fact that the mutant phenotype was caused by disruption of TGFβ signaling in tenocytes 428 and the rescue of the tendon cell fate by virus mediated reintroduction of Tgfbr2 even to 429 individual mutant cells provides direct evidence for a continuous and cell autonomous role for 430 TGFβ signaling in maintenance of the tendon cell fate. However, targeting of Tgfbr2 using both 431 tendon specific and ubiquitous inducible Cre drivers at different developmental stages did not 432 result in tenocyte dedifferentiation, suggesting that tenocyte dedifferentiation in these mutants 433 was dependent on specific spatial and temporal features of the ScxCre driver. These 434 observations suggest that tenocyte dedifferentiation in these mutants may not merely be the 435 result of the loss of intrinsic TGFβ signaling in tendon cells, but rather may be caused by an 436 interplay between intrinsic loss of TGFβ signaling and additional external factors contributed by 437 the environment of the mutant tendons, e.g. cell-cell or cell-matrix interaction. 438 The tendon phenotype of Tgfbr2;ScxCre mutants highlights a likely role for tenocyte 439 dedifferentiation in regenerative processes in tendons and possibly also in the progression of 440 tendon pathology. Uncovering the molecular pathways involved in this process may therefore 441 be important for new strategies for treatments of tendon pathologies. The Tgfbr2;ScxCre 442 mutants provide a unique opportunity to analyze these pathways, and the experimental 443 approaches employed in this study may be developed into an experimental paradigm for 444 molecular dissection of this process. Briefly, transcriptional and epigenetic analyses of the 445 mutant tenocytes through the dedifferentiation process can provide a landscape of the 446 molecular changes that initiate and drive the dedifferentiation process. Promising candidates 447 can then be tested using the AAV-mediated cell fate rescue experiments to identify genes or 448 groups of genes that can protect the tenocytes from dedifferentiation to establish the 449 molecular process of cellular dedifferentiation. Of particular interest will be the early molecular 450 changes in the mutant tenocytes that drive and promote the onset and progression of tenocyte 451 dedifferentiation. 452 Our findings underscore the fact that the tendon cell fate requires continuous maintenance 453 and that it is not an irreversible state, a long-standing biological dogma that has been 454 challenged by recent research (Takahashi and Yamanaka, 2006; Ladewig et al., 2013) . 455 Nevertheless, it is important to recognize that the dramatic cell fate changes in Tgfbr2;ScxCre 456 mutant happens in the context of a genetic modification. The occurrence of such phenomenon 457 in vivo might not be a simple direct outcome of changes to TGF signaling. Most importantly, 458 while the initiating events for tenocyte dedifferentiation may vary in different scenarios, it is 459 likely that the molecular events that drive the dedifferentiation process downstream of the 460 initiation event are similar or related. Uncovering these pathways in this experimental system 461 may therefore facilitate the analysis of such processes in various other contexts. 822  823  824  825  826  827  828  829  830  831  832  833  834  835  836  837  838  839  840  841  842  843  844  845 
